DXR
Daxor CorpCompany with tickers: DXR
CIK
27367
CUSIP
239467103
Shares Outstanding
5,838,224
13F Activity (30d)
2 filings
1 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,446,345 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $652,511 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| Gross Profit | $793,834 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| Operating Expenses | $6,580,248 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| Research & Development | $2,705,952 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| Operating Income | $-5,786,414 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| Net Income | $-7,185,639 | USD | 2011-12-31 | 10-K | 2012-03-28 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |